Cargando…
Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
With an estimated 6.2 million adults affected in the USA, heart failure remains a leading cause of morbidity, mortality, and health-care costs, despite the use of guideline-based medical therapies. The search for a more efficient therapy was rekindled when findings from the Prospective Comparison of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405908/ https://www.ncbi.nlm.nih.gov/pubmed/32801725 http://dx.doi.org/10.2147/TCRM.S224772 |